185 related articles for article (PubMed ID: 6365657)
21. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
Zavaroni I; Reaven GM
Metabolism; 1981 Apr; 30(4):417-20. PubMed ID: 7010078
[TBL] [Abstract][Full Text] [Related]
22. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
Lecavalier L; Hamet P; Chiasson JL
Diabete Metab; 1986 Jun; 12(3):156-61. PubMed ID: 3525270
[TBL] [Abstract][Full Text] [Related]
23. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio F; Compagnucci P
Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
25. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
[TBL] [Abstract][Full Text] [Related]
26. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
Schöffling K; Hillebrand I
Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
[No Abstract] [Full Text] [Related]
27. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
28. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
Kotler DP; Tierney AR; Kral JG; Bjorntorp P
Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
[TBL] [Abstract][Full Text] [Related]
29. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice.
Lee SM; Bustamante SA; Koldovský O
Metabolism; 1983 Aug; 32(8):793-9. PubMed ID: 6346004
[No Abstract] [Full Text] [Related]
30. Pharmacology of alpha-glucosidase inhibition.
Bischoff H
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man.
Lembcke B; Fölsch UR; Gatzemeier W; Ebert R; Siegel E; Creutzfeldt W
Pharmacology; 1991; 43(6):318-28. PubMed ID: 1784628
[TBL] [Abstract][Full Text] [Related]
32. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
Madar Z; Melamed EC; Zimlichman R
Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
[TBL] [Abstract][Full Text] [Related]
33. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome.
Lyons TJ; McLoughlin JC; Shaw C; Buchanan KD
Digestion; 1985; 31(2-3):89-96. PubMed ID: 3888753
[TBL] [Abstract][Full Text] [Related]
34. Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man.
Scheen AJ; de Magalhaes AC; Salvatore T; Lefebvre PJ
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():50-4. PubMed ID: 7818725
[TBL] [Abstract][Full Text] [Related]
35. Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption.
Taylor RH; Jenkins DJ; Barker HM; Fielden H; Goff DV; Misiewicz JJ; Lee DA; Allen HB; MacDonald G; Wallrabe H
Diabetes Care; 1982; 5(2):92-6. PubMed ID: 6927727
[TBL] [Abstract][Full Text] [Related]
36. [Nutrient digestibility and N-balance after administration of an alpha-glucosidase inhibitor to pigs].
Roth FX; Kirchgessner M
Z Tierphysiol Tierernahr Futtermittelkd; 1980; 44(2):57-63. PubMed ID: 6252715
[No Abstract] [Full Text] [Related]
37. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Krause HP; Keup U; Thomas G; Puls W
Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
[TBL] [Abstract][Full Text] [Related]
38. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
39. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
Hayakawa T; Noda A; Kondo T; Okumura N
Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
[No Abstract] [Full Text] [Related]
40. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
